SCHEMBL23970524

SCHEMBL23970524

COc1cccc(CCCCCO)c1C(=O)OC(C)(C)C

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 1/20 0.56
HDAC6 Q9UBN7 1/20 0.56
PPARA Q07869 2/20 0.55
ALOX5 P09917 1/20 0.42
PTGS2 P35354 1/20 0.42
PPARG P37231 1/20 0.41
BCHE P06276 3/20 0.41
ACHE P22303 3/20 0.41
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA7 P43166 1/20 0.40
CA9 Q16790 1/20 0.40
CA14 Q9ULX7 1/20 0.40
CYP4F2 P78329 1/20 0.39
CYP4A11 Q02928 1/20 0.39
ITGA4 P13612 1/20 0.37
ITGB7 P26010 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30159096 1.00 HDAC1 (0.56) HDAC1HDAC6PPARAALOX5PTGS2
SCHEMBL30159187 0.84 PPARA (0.39) HDAC1HDAC6PPARAPPARGCYP4F2
SCHEMBL23971426 0.84 PPARA (0.39) HDAC1HDAC6PPARAPPARGCYP4F2
SCHEMBL23970752 0.83 PPARA (0.39) HDAC1HDAC6PPARAPPARGCYP4F2
SCHEMBL23971318 0.80 PPARA (0.36) HDAC1HDAC6PPARAPPARGCYP4F2
SCHEMBL28390734 0.77 GRM6 (0.39) HDAC1HDAC6PPARAPPARGCYP4F2
SCHEMBL23970600 0.77 ALDH1A1 (0.43) CYP4F2CYP4A11
SCHEMBL2945568 0.76 PPARA (0.77) HDAC1HDAC6PPARAALOX5PTGS2
SCHEMBL20124014 0.76 PPARA (0.77) HDAC1HDAC6PPARAALOX5PTGS2
SCHEMBL9720220 0.75 ALDH1A1 (0.44) CYP4F2CYP4A11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11976083-B2 Inhibitors of peptidylarginine deiminases GILEAD SCIENCES, INC. (US) 2024-05-07 US disclosed
CN-115551862-B Macrocyclic inhibitors of peptidyl arginine deiminase 吉利德科学公司 2024-04-12 CN disclosed
EP-4143189-A1 MACROCYCLIC INHIBITORS OF PEPTIDYLARGININE DEIMINASES GILEAD SCIENCES, INC. (US) 2023-03-08 EP disclosed
US-20230002412-A1 INHIBITORS OF PEPTIDYLARGININE DEIMINASES GILEAD SCIENCES, INC. 2023-01-05 US disclosed
US-20230002412-A1 INHIBITORS OF PEPTIDYLARGININE DEIMINASES GILEAD SCIENCES, INC. 2023-01-05 US disclosed
CN-115551862-A Macrocyclic inhibitors of peptidyl arginine deiminase 吉利德科学公司 2022-12-30 CN disclosed
WO-2021222353-A1 MACROCYCLIC INHIBITORS OF PEPTIDYLARGININE DEIMINASES GILEAD SCIENCES, INC. (US) 2021-11-04 WO disclosed
WO-2021222353-A1 MACROCYCLIC INHIBITORS OF PEPTIDYLARGININE DEIMINASES GILEAD SCIENCES, INC. (US) 2021-11-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11976083-B2 Inhibitors of peptidylarginine deiminases PADI4, PADI2, PADI1 HDAC1 712/4885HDAC6 711/4885PPARA 2993/4885
US-20230002412-A1 INHIBITORS OF PEPTIDYLARGININE DEIMINASES PADI4, PADI2, PADI1 HDAC1 712/4885HDAC6 711/4885PPARA 2993/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.